Trial: 202111197

A Phase I/IIa Multi-center, Open-label Master Protocol to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumor Activity of AZD8205 in Participants with Advanced or Metastatic Solid Malignancies

Phase

I/II

Principal Investigator

Park, Haeseong

Disease Site

Anus; Breast; Cervix; Colon; Corpus Uteri; Esophagus; Liver; Other Digestive Organ; Other Female Genital; Ovary; Pancreas; Rectum; Small Intestine; Stomach

Learn more about this study at: clinicaltrials.gov